The grant is expected to provide approximately US$3.6 million over three years to support the Phase 1 clinical development of the company’s lead molecule, KNX100, to treat symptoms associated with withdrawal in patients with opioid use disorder. …
Kinoxis Therapeutics secures US government grant to progress drug development
June 7, 2023 Australian Biotech
Latest Video
New Stories
-
New partnership promotes buy local for homegrown innovation
May 8, 2025 - - Latest News -
New Zealand to change laws to promote medical conferences
May 8, 2025 - - Latest News -
Australia is about to get a new industry minister
May 8, 2025 - - Latest News -
Internal promotions for new generation of leaders at Astellas
May 7, 2025 - - Latest News -
New study reveals the far-reaching impact of ovarian cancer
May 7, 2025 - - Latest News -
Just the threat of tariffs has secured a quarter of a trillion in investment
May 7, 2025 - - Latest News -
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech